Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Non Operating Income (2019 - 2025)

Historic Non Operating Income for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $758000.0.

  • Pulmonx's Non Operating Income rose 47711.44% to $758000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $886000.0, marking a year-over-year increase of 59775.28%. This contributed to the annual value of $256000.0 for FY2024, which is 13803.86% up from last year.
  • As of Q3 2025, Pulmonx's Non Operating Income stood at $758000.0, which was up 47711.44% from -$116000.0 recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Non Operating Income ranged from a high of $758000.0 in Q3 2025 and a low of -$432000.0 during Q3 2022
  • Over the past 5 years, Pulmonx's median Non Operating Income value was -$106000.0 (recorded in 2021), while the average stood at -$32722.2.
  • In the last 5 years, Pulmonx's Non Operating Income tumbled by 27761.19% in 2023 and then surged by 47711.44% in 2025.
  • Quarter analysis of 5 years shows Pulmonx's Non Operating Income stood at -$383000.0 in 2021, then surged by 152.48% to $201000.0 in 2022, then tumbled by 277.61% to -$357000.0 in 2023, then surged by 121.57% to $77000.0 in 2024, then soared by 884.42% to $758000.0 in 2025.
  • Its Non Operating Income stands at $758000.0 for Q3 2025, versus -$116000.0 for Q2 2025 and $167000.0 for Q1 2025.